Brief: Algernon Says Lead Drugs For NASH And Chronic Kidney Disease Are Bemethyl And Bromantane

Grey Matters Health

31/07/2019 12:25

July 31 (Reuters) - Algernon Pharmaceuticals Inc  AGN.CD :
    * ALGERNON PHARMACEUTICALS -CO'S LEAD DRUGS FOR
NON-ALCOHOLIC
STEATOHEPATITIS AND CHRONIC KIDNEY DISEASE ARE BEMETHYL (NP-135)
AND BROMANTANE (NP-160)
    * ALGERNON - NP-135 (BEMETHYL) AND NP-160 (BROMANTANE),
SHOWED
HIGHLY STATISTICALLY SIGNIFICANT ANTI-FIBROTIC ACTIVITY IN BOTH
NASH & CKD DISEASE MODELS

Source text for Eikon:  ID:nGNX3gPhxD 
Further company coverage:  AGN.CD 

 ((Reuters.Briefs@thomsonreuters.com;))